Skip To Main Content
Huan Yin on Muck Rack

Huan Yin

As seen in: Nature, Wiley Online Library, arXiv, PLOS ONE, MDPI, Taylor & Francis Online, Royal Society of Chemistry, Dove Medical Press, Dialnet - Universidad de La Rioja
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Huan

Contact Huan, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Ursodeoxycholic acid enhances cancer radioimmunotherapy by releasing a human-biased FXR-TRIM22-STAT1 immune brake

|
By Xinyan Li, Huan Yin, Zhenyu Huo, Xin Xu, Somaira Nowsheen, Khaled Aziz, Sufei Zheng, Nan Sun, Bin Chen, Zhenkun Lou, Min Deng, Peicheng Jiang
| Nature Verified
Abstract Radiotherapy is a fundamental modality in cancer treatment, used in the management of more than half of cancer patients. Beyond direct cytotoxicity, ionizing radiation activates innate immune pathways and inflammatory cytokines required for local tumor control and systemic (abscopal) responses. Yet in human tumors, DNA damage-induced immune activation is attenuated compared with the robust responses observed in mice, suggesting a human-biased checkpoint that constrains radioimmunity.
Open in Who Shared Issue with article?

Computer Science > Robotics

|
By Huan Yin, Yang Xu, Shuo Liu
| arXiv
arXivLabs is a framework that allows collaborators to develop and share new arXiv features directly on our website. Both individuals and organizations that work with arXivLabs have embraced and accepted our values of openness, community, excellence, and user data privacy. arXiv is committed to these values and only works with partners that adhere to them. Have an idea for a project that will add value for arXiv's community? Learn more about arXivLabs.
Open in Who Shared View Duplicates (220) Issue with article?

Efficacy and Safety of PHPV Fusion Factor Vaginal Gel (PHPV®) in Clearing Cervical Persistent High-Risk Human Papillomavirus Infection: A Randomized Controlled Clinical Trial

|
By Huan Yin, Liye Shi, Bingxue Ding
| Taylor & Francis Online
Abstract Purpose To evaluate the efficacy and safety of PHPV in the treatment of persistent high-risk papillomavirus (hrHPV) infection of the cervix. Patients and Methods A randomized controlled trial (RCT) was conducted on patients with persistent hrHPV infection which were randomly assigned in three groups: PHPV, interferon and control. All participants were followed up at baseline, 3 months and 6 months after enrollment. The primary outcome was hrHPV clearance at 6 months post-enrollment.
Open in Who Shared View Duplicates (2) Issue with article?
See all 20 articles